Kolexia
Capitain Olivier Oncologie médicale
Capitain Olivier
Oncologie médicale
Ico - Site Paul Papin
Angers, France
111 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Carcinome épidermoïde Tumeurs colorectales Carcinome épidermoïde de la tête et du cou Métastase tumorale Tumeurs de la tête et du cou Tumeurs du sein Déficit en dihydropyrimidine déshydrogénase Récidive tumorale locale

Collaborateurs

Voir plus
Guerin-Meyer Veronique
Guerin-Meyer Veronique
Ico - Site Paul Papin, Angers, France
Metges Jean-Philippe
Metges Jean-Philippe
Hôpital Morvan, Brest, France
Lecomte Thierry
Lecomte Thierry
Hôpital Trousseau Chambray lès Tours, Chambray-lès-Tours, France
Lam You-Heng
Lam You-Heng
Centre Hospitalier de Cholet, Cholet, France

Industries

Voir plus
Servier
15 collaboration(s)
Dernière en 2023
Merck-Serono
7 collaboration(s)
Dernière en 2023
MSD
5 collaboration(s)
Dernière en 2023
Sanofi
5 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity.
Scientific reports   18 décembre 2023
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients.
British journal of clinical pharmacology   10 décembre 2023
1617P PRODIGE 29-UCGI 26 (NEOPAN): Quality of life results of a phase III randomised trial comparing chemotherapy with folfirinox (FFX) or gemcitabine (gem) in locally advanced pancreatic carcinoma (LAPC)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers: A Phase Ib/II Trial Evaluating the Combination of TG4001 and Avelumab in Patients With HPV-16 Positive Recurrent or Metastatic Malignancies.
Essai Clinique (Transgene)   01 août 2023
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients.
Clinical pharmacokinetics   13 juillet 2023
Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers.
European journal of cancer (Oxford, England : 1990)   11 juillet 2023
1296MO PRODIGE 29-UCGI 26(NEOPAN): A phase III randomised trial comparing chemotherapy with folfirinox or gemcitabine in locally advanced pancreatic carcinoma (LAPC)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
TPExtreme: Randomized, Controlled Trial of Platinum-Cetuximab Combined Either With Docetaxel (TPEx) or With 5FU (Extreme) in Patients With Recurrent/Metastatic Squamous Cell Cancer of the Head and Neck
Essai Clinique (Groupe d'Oncologie Radiothérapie Tête Et Cou)   22 août 2022
70P Outcomes in patients treated with taxane regimen after immune checkpoint inhibitors failure in advanced or metastatic non-small cell lung cancer
ESMO Immuno-Oncology Congress 2021 08-11 December 2021   01 décembre 2021
Academic carriers in oncology and radiotherapy: Update for the readers of Bulletin du Cancer.
Bulletin du cancer   20 septembre 2021